Literature DB >> 1528711

Stability of total parenteral nutrition supplied as 'all-in-one' for children with chemotherapy-linked hyperhydration.

M J Korrenhof1, J G Timmer.   

Abstract

The maximal allowable concentrations of calcium and phosphate in total parenteral nutrition mixtures for children from one compartment were investigated. Children treated with both chemotherapy and total parenteral nutrition are supplied with high amounts of electrolytes (besides normal nutritive needs) in a restricted volume. Such nutritive mixtures are suspected of precipitation and disintegration of the lipid emulsion by (polyvalent) electrolytes, such as calcium and phosphate. Calcium (range 1.5-150 mmol/l total parenteral nutrition) and phosphate (range 21-300 mmol/l) were added to a test total parenteral nutrition mixture. After storage (24 and 48 h) at both 22 degrees C and 37 degrees C the mixtures were observed by microscopy for the presence of precipitates. The stability of the fat emulsion was visually assessed and the particle size distribution was measured by flow cytometry. The examined total parenteral nutrition mixtures (pH 5.4-5.7) were stable during 48 h at 37 degrees C if the calcium concentration is below 16 mmol/l, the phosphate concentration is below 52 mmol/l and the product of both concentrations is below 250 mmol2/l2.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1528711     DOI: 10.1007/bf01980482

Source DB:  PubMed          Journal:  Pharm Weekbl Sci        ISSN: 0167-6555


  12 in total

1.  The compatibility of calcium phosphate in paediatric TPN infusions.

Authors:  M C Allwood
Journal:  J Clin Pharm Ther       Date:  1987-10       Impact factor: 2.512

2.  Dressing changes by specialized personnel reduce infection rates in patients receiving central venous parenteral nutrition.

Authors:  D B Nelson; C L Kien; B Mohr; S Frank; S D Davis
Journal:  JPEN J Parenter Enteral Nutr       Date:  1986 Mar-Apr       Impact factor: 4.016

3.  Calcium and phosphate solubility in neonatal parenteral nutrient solutions containing TrophAmine.

Authors:  K A Fitzgerald; M W MacKay
Journal:  Am J Hosp Pharm       Date:  1986-01

4.  Compatibility considerations in parenteral nutrient solutions.

Authors:  P W Niemiec; T W Vanderveen
Journal:  Am J Hosp Pharm       Date:  1984-05

5.  Compatibility and stability of electrolytes, vitamins and antibiotics in combination with 8% amino acids solution.

Authors:  D H Schuetz; J C King
Journal:  Am J Hosp Pharm       Date:  1978-01

6.  Calcium and phosphate solubility in neonatal parenteral nutrient solutions containing Aminosyn PF.

Authors:  K A Fitzgerald; M W MacKay
Journal:  Am J Hosp Pharm       Date:  1987-06

7.  Compatibility of common additives in protein hydrolysate/dextrose solutions.

Authors:  N H Kobayashi; J C King
Journal:  Am J Hosp Pharm       Date:  1977-06

8.  Calcium and phosphate requirements of preterm infants who require prolonged hyperalimentation.

Authors:  P J Knight; S Buchanan; H W Clatworthy
Journal:  JAMA       Date:  1980-03-28       Impact factor: 56.272

9.  Calcium and phosphate solubility in neonatal parenteral nutrient solutions containing Aminosyn-PF or TrophAmine.

Authors:  G T Lenz; B A Mikrut
Journal:  Am J Hosp Pharm       Date:  1988-11

10.  Compatibility of calcium chloride and calcium gluconate with sodium phosphate in a mixed TPN solution.

Authors:  R S Henry; R W Jurgens; R Sturgeon; N Athanikar; A Welco; M Van Leuven
Journal:  Am J Hosp Pharm       Date:  1980-05
View more
  2 in total

1.  Compatibility of intravenous ibuprofen with lipids and parenteral nutrition, for use as a continuous infusion.

Authors:  Jowell Garcia; Alka Garg; Yunmei Song; Ambados Fotios; Chad Andersen; Sanjay Garg
Journal:  PLoS One       Date:  2018-01-03       Impact factor: 3.240

2.  Development and evaluation of a test program for Y-site compatibility testing of total parenteral nutrition and intravenous drugs.

Authors:  Vigdis Staven; Siri Wang; Ingrid Grønlie; Ingunn Tho
Journal:  Nutr J       Date:  2016-03-22       Impact factor: 3.271

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.